A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 187-197

  Audinot, Valérie ^a   Newman Tancredi, Adrian ^a   Gobert, Alain ^a   Rivet, Jean Michel ^a   Brocco, Mauricette ^a   Lejeune, Françoise ^a   Gluck, Laurence ^a   Desposte, Isabelle ^a   Bervoets, Karin ^a   Dekeyne, Anne ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(5,6 DIMETHOXYINDAN 2 YL)DIPROPYLAMINE; 2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 4' ACETYL N [4 [(2 METHOXYPHENYL)PIPERAZIN 1 YL]BUTYL]BIPHENYL 4 CARBOXAMIDE; 4' ACETYL N [4 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]BUTYL]BIPHENYL 4 CARBOXAMIDE; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; 7 DIPROPYLAMINO 2,3,5,6,7,8 HEXAHYDRONAPHTHO[2,3 B]FURAN; BENZAMIDE DERIVATIVE; BENZOFURAN DERIVATIVE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; HALOPERIDOL; INDAN DERIVATIVE; NAFADOTRIDE; PIPERAZINE DERIVATIVE; PRAZOSIN; PROLACTIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALEPSY; CHO CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; RECEPTOR AFFINITY; SEROTONINERGIC NERVE CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

2-NAPHTHYLAMINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BENZOPYRANS; BINDING, COMPETITIVE; BIPHENYL COMPOUNDS; BODY TEMPERATURE; CATALEPSY; DOPAMINE; DOPAMINE ANTAGONISTS; FURANS; HUMANS; INDANS; NAPHTHALENES; OXAZINES; PIPERAZINES; PROLACTIN; PYRROLIDINES; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0032463041     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci 93:1945-1949.
2. 3 receptor ligands. Eur J Pharmacol 281:R7-R9.
3. 3 receptor agonist ligand, to CHO-K1 cells. Life Sci 15:1401-1410.
4. 2 receptors. Lett Nature (Lond) 377:424-428.
5. Ben-Jonathan N, Arbogast LA and Hyde JF (1989) Neuroendocrine regulation of prolactin release. Prog Neurobiol 33:399-447.
6. 2 agonists on tuberoinfundibular dopamine neurons. J Pharmacol Exp Ther 254:677-682.
7. 2 receptor mRNA. Brain Res 564:203-219.
8. Bowery B, Rothwell LA and Seabrook GR (1994) Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Br J Pharmacol 112:873-880.
9. 2 receptor antagonist L-741,626. Br J Pharmacol 119:1491-1497.
10. 4 antagonists. J Med Chem 39:1946-1948.
11. 3 receptor agonist, (+)-PD 128,907, in the rat. Neuropharmacology 35:285-294.
12. 4 receptor antagonist. Trends Pharmacol Sci 18:186-188.
13. 3 receptor blockade does not inhibit motor behaviour and reduces haloperidol-induced catalepsy (Abstract). Am Soc Neurosci 21:618.
14. Caine SB and Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science (Wash DC) 260:1814-1816.
15. 3 dopamine receptor function in knockout mice (Abstract). Am Soc Neurosci 22:1088.
16. Casey DE (1993) Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in non-human primates. Psychopharmacology 112: S55-S59.
17. 2 dopamine receptors. Mol Pharmacol 45:51-61.
18. Creese I and Fraser CM (1987) Receptor Biochemistry and Methodology, vol 8, Dopamine Receptors. Alan R. Liss Inc., New York.
19. 3 receptor agonist 7-OH-DPAT: Comparison with quinpirole and apomorphine. Psychopharmacology 124:231-240.
20. Devoto P, Collu M, Muntoni L, Pistis M, Serra G, Gessa GL and Diana M (1995) Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic systems. Synapse 20:153-155.
21. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6:1384-1387.
22. 3 receptor in the rat brain. Neuroscience 65:731-745.
23. Eriksson E, Carlsson M, Clark D, Nilsson C and Svensson K (1986) Compounds with selectivity for dopamine autoreceptors: Effects of prolactin secretion in male and female rats. Clin Neuropharmacol 9:226-228.
24. 3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats. Neurosci Lett 193:65-67.
25. 3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur J Pharmacol 308:261-269.
26. 3 receptors in rat brain. Eur J Pharmacol 211:189-192.
27. 3 (auto) receptor inhibits dopamine release in the frontal cortex of freely-moving rats in vivo. J Neurochem 66:2209-2212.
28. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J Pharmacol Exp Ther 275:899-913.
29. 3 receptor ligand, (+)-UH 232, is a partial agonist. Eur J Pharmacol 282:R3-R4.
30. 2 dopamine receptors. Br J Pharmacol 121:731-736.
31. 3H]PD 128907. Psychopharmacology 128:240-247.
32. 3H]-7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res 648:222-228.
33. 1A receptors: Behavioural and in vivo brain microdialysis studies. Life Sci 46:955-963.
34. 3 receptor antagonist GR 103,691 with typical and atypical neuroleptics. Eur J Pharmacol 318:283-293.
35. Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463.
36. 3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology 122:351-357.
37. 3-preferring compounds in discrete areas of the rat brain. J Neural Transm 102:209-220.
38. 3 receptor mutant mice. J Neurosci 18:2231-2238.
39. 4 receptor. J Med Chem 39: 1941-1942.
40. 2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: Relationship to dopamine stimulation of tyrosine phosphorylations. J Pharmacol Exp Ther 267:1573-1581.
41. 3 receptor mRNA and binding sites in human brain. Mol Brain Res 18:187-192.
42. 2 dopamine receptors: Visualization of cellular expression patterns in motor and limbic structures. Synapse 20:325-337.
43. 1A receptors. Eur J Pharmacol 260:79-83.
44. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur J Pharmacol 275:R7-R9.
45. 2 dopamine receptors. Neuroscience 73:131-143.
46. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol Rev 49:231-252.
47. 3 dopamine receptors in rat brain and pituitary gland: A quantitative autoradiographic study. J Pharmacol Exp Ther 264:991-1001.
48. 3 receptor functions. Bioch Pharmacol 52:511-518.
49. 3H]-7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci 89:8155-8159.
50. 2 receptor can mediate dopaminergic repression of the rat prolactin promoter. Mol Cell Endocrinology 79:R1-R7.
51. 2 dopamine receptor. Mol Cell Endocrinol 36:201-209.
52. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL and Watson SJ (1996) Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29.
53. 4 receptor selective antagonist. J Pharmacol Exp Ther 279:1392-1403.
54. 2 receptor deficient mice. Neuroscience 79:323-327.
55. 3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Eur J Pharmacol 260:R3-R5.
56. 3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats. Eur J Pharmacol 321:R7-R9.
57. 4 receptors: An in vitro and in vivo comparison to L-745,870 (3-(4-[4-chlorophenyl)piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and raclopride. J Pharmacol Exp Ther, in press.
58. 4 receptors (Abstract). Am Soc Neuroscience 22: 1772.
59. 2 receptors elicits prolactin secretion and catalepsy. J Pharmacol Exp Ther 275:885-898.
60. 2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro. Br J Pharmacol 109:933-940.
61. 3 receptors. Br J Pharmacol Proc 122:279P.
62. 3 receptor. Bioorganic Med Chem Lett 5:219-222.
63. 3 receptor. Bioorganic Med Chem Lett 6:403-408.
64. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci 91:11271-11272.
65. 3 receptors. Neuropharmacology 34:1693-1696.
66. 2 receptor is antagonised by R(-)-n-propylanorapomorphine, raclopride and phenoxybenzamine. Neuropsychopharmacology 15:53-61.
67. 4 receptors. J Pharmacol Exp Ther 277:186-192.
68. 2 receptor subtype. Eur J Pharmacol 317:29-38.
69. 3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay. Mol Brain Res 33:97-103.
70. 3 receptor antagonist, (+)-S 14297. Eur J Pharmacol 265:175-177.
71. 2 agonist, in Monitoring Molecules in Neuroscience, Proceedings of the 6th Intern. Conf. on in vivo Methods, González-Mora JL, Borges R and Mas E (eds) pp 93-94.
72. Roberts DCS and Ranaldi R (1995) Effect of dopaminergic drugs on cocaine reinforcement. Clin Neuropharmacol 18:S84-S95.
73. 2 receptors in the regulation of body temperature in the rat. Eur J Pharmacol 236:395-400.
74. 3 receptors in the effects of dopamine agonists on operant behaviour in rats. Behav Pharmacol 7:477-482.
75. 2 receptors. NeuroReport 6:329-332.
76. 3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275:1239-1246.
77. Seabrook GR, Patel S, Hutson PH, Ragan CI and Bristow LJ (1995) Functional relevance of dopamine receptors. Trends Pharmacol Sci 16:406-407.
78. 2 receptor. Eur J Pharmacol 225:331-337.
79. Sokoloff P and Schwartz J-C (1995) Novel dopamine receptors half a decade later. Trends Pharmacol Sci 16:270-275.
80. 3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 278:1128-1137.
81. Strange PG (1993) New insights into dopamine receptors in the central nervous system. Neurochem Int 22:223-236.
82. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A and Kitai ST (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci 89:10178-10182.
83. 3 receptors. Eur J Pharmacol 263:235-243.
84. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268:495-502.
85. 3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci 17:2519-2530.
86. 2 agonist binding for determination of receptor subtype selectivity. J Med Chem 39:4233-4237.
87. Waldemeier PC and Delini-Stula AA (1979) Serotonin-dopamine interactions in the nigrostriatal system. Eur J Pharmacol 55:363-373.
88. 3 receptors. Synapse 23: 152-163.
89. Waters N, Hansson L, Löfberg L and Carlsson A (1994a) Intracerebral infusion of (+)-AJ 76 and (+)-UH 232: Effects on dopamine release and metabolism in vivo. Eur J Pharmacol 251:181-190.
90. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J Neural Transm 98:39-55.
91. 3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm 94:11-19.
92. Willner P (1983) Dopamine and depression. A review of recent evidence. III. The effects of antidepressant treatments. Brain Res Rev 6:237-246.